Mitrabara Adiperdana Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Mitrabara Adiperdana Tbk. trades at Rp1,385 (market cap 1.7T, 6.7K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Mitrabara Adiperdana Tbk. is far larger — about 10.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (96.7K versus 6.7K). Which is the better fit depends on your goals.
| MBAP | OBAT | |
|---|---|---|
Market Cap | 1.7T | 167.37B |
Volume | 6.7K | 96.7K |
Lot | 67 | 967 |
Turnover | 9.31M | 23.82M |
Average Price | 1,389.18 | 246.34 |
Value | 9.31M | 23.82M |
Indicative Equilibrium Price | 1,385 | 248 |
Indicative Equilibrium Volume | 100 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Mitrabara Adiperdana Tbk (the Company) was established in the Republic of Indonesia under its initial name of PT Mitrabara Adiperdana on May 29, 1992 based on the Notarial Deed No. 34 of H.A. Kadir Usman, S.H.
Read more on MBAP →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →